Variant report

Variant	esv1796109
Chromosome Location	chr10:50323229-50326725
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:174)
CpG islands
(count:428)
Chromatin interactive
region (count:6)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:174 , 50 per page) page: 1 2 3 4

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr10:50323742-50323798	K562	blood:	n/a	n/a
2	ATF3	chr10:50323426-50323778	K562	blood:	n/a	chr10:50323542-50323562
3	BACH1	chr10:50322997-50323317	H1-hESC	embryonic stem cell:	n/a	n/a
4	BACH1	chr10:50323658-50323952	H1-hESC	embryonic stem cell:	n/a	n/a
5	BATF	chr10:50324193-50324568	GM12878	blood:	n/a	n/a
6	BHLHE40	chr10:50323013-50323326	K562	blood:	n/a	n/a
7	BHLHE40	chr10:50323737-50323937	K562	blood:	n/a	n/a
8	BRCA1	chr10:50323099-50323329	H1-hESC	embryonic stem cell:	n/a	n/a
9	CBX3	chr10:50323554-50323957	K562	blood:	n/a	n/a
10	CBX3	chr10:50323620-50323895	K562	blood:	n/a	n/a
11	CCNT2	chr10:50323077-50323857	K562	blood:	n/a	chr10:50323655-50323664
12	CEBPB	chr10:50325483-50325774	K562	blood:	n/a	chr10:50325613-50325626 chr10:50325613-50325624 chr10:50325634-50325645 chr10:50325613-50325626
13	CEBPB	chr10:50325467-50325766	HepG2	liver:	n/a	chr10:50325613-50325626 chr10:50325613-50325624 chr10:50325634-50325645 chr10:50325613-50325626
14	CHD2	chr10:50323045-50323384	H1-hESC	embryonic stem cell:	n/a	n/a
15	CHD2	chr10:50322965-50323427	K562	blood:	n/a	n/a
16	CHD2	chr10:50323123-50323273	HepG2	liver:	n/a	n/a
17	CHD2	chr10:50324251-50324451	GM12878	blood:	n/a	n/a
18	CTCF	chr10:50323200-50323350	GM12871	blood:	n/a	n/a
19	CTCF	chr10:50323476-50323582	Kidney_OC	kidney:	n/a	n/a
20	CTCF	chr10:50323220-50323343	ProgFib	skin:	n/a	n/a
21	CTCF	chr10:50323400-50323550	GM12865	blood:	n/a	n/a
22	CTCF	chr10:50323264-50323334	GM12891	blood:	n/a	n/a
23	CTCF	chr10:50323180-50323330	HRE	kidney:	n/a	n/a
24	CTCF	chr10:50323160-50323310	GM12866	blood:	n/a	n/a
25	CTCF	chr10:50323240-50323390	WERI-Rb-1	eye:	n/a	n/a
26	CTCF	chr10:50323181-50323398	Fibrobl	skin:	n/a	n/a
27	CTCF	chr10:50323143-50323676	GM19238	blood:	n/a	n/a
28	CTCF	chr10:50323285-50323398	GM13977	blood:	n/a	n/a
29	CTCF	chr10:50323363-50323366	GM12891	blood:	n/a	n/a
30	CTCF	chr10:50323540-50323547	GM13977	blood:	n/a	n/a
31	CTCF	chr10:50323470-50323596	SK-N-SH_RA	brain:	n/a	n/a
32	CTCF	chr10:50323460-50323610	HUVEC	blood vessel:	n/a	n/a
33	CTCF	chr10:50323499-50323616	GM12891	blood:	n/a	n/a
34	CTCF	chr10:50323180-50323330	AG04449	skin:	n/a	n/a
35	CTCF	chr10:50323145-50323716	K562	blood:	n/a	n/a
36	CTCF	chr10:50323220-50323370	GM12872	blood:	n/a	n/a
37	CTCF	chr10:50323094-50323802	K562	blood:	n/a	n/a
38	CTCF	chr10:50323495-50323594	Gliobla	brain:	n/a	n/a
39	CTCF	chr10:50323244-50323365	A549	lung:	n/a	n/a
40	CTCF	chr10:50323501-50323602	GM10248	blood:	n/a	n/a
41	CTCF	chr10:50323258-50323273	Spleen_OC	spleen:	n/a	n/a
42	CTCF	chr10:50323511-50323579	ProgFib	skin:	n/a	n/a
43	CTCF	chr10:50322934-50323640	K562	blood:	n/a	n/a
44	CTCF	chr10:50323290-50323379	GM13976	blood:	n/a	n/a
45	CTCF	chr10:50323420-50323570	K562	blood:	n/a	n/a
46	CTCF	chr10:50323228-50323395	GM19239	blood:	n/a	n/a
47	CTCF	chr10:50323220-50323370	SK-N-SH_RA	brain:	n/a	n/a
48	CTCF	chr10:50326709-50326713	LNCaP	prostate:	n/a	n/a
49	CTCF	chr10:50323479-50323600	GM10266	blood:	n/a	n/a
50	CTCF	chr10:50323512-50323630	Pancreas_OC	pancreas:	n/a	n/a

(count:428 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr10:50323829-50323879	BJ	skin:	n/a
2	chr10:50323829-50323879	BJ	skin:	n/a
3	chr10:50323832-50323882	GM12878	blood:	n/a
4	chr10:50323832-50323882	AG09309	skin:	n/a
5	chr10:50323708-50323758	HRE	kidney:	n/a
6	chr10:50323244-50323294	HL-60	blood:	n/a
7	chr10:50323706-50323756	A549	lung:	n/a
8	chr10:50323832-50323882	HIPEpiC	eye:	n/a
9	chr10:50323369-50323419	PFSK-1	brain:	n/a
10	chr10:50323706-50323756	Hela-S3	cervix:	n/a
11	chr10:50323369-50323419	IMR90	lung:	fetal
12	chr10:50323829-50323879	MCF10A-Er-Src	breast:	n/a
13	chr10:50323708-50323758	HCT-116	colon:	n/a
14	chr10:50323832-50323882	HL-60	blood:	n/a
15	chr10:50323706-50323756	NHDF-neo	bronchial:	n/a
16	chr10:50323832-50323882	HEEpiC	esophagus:	n/a
17	chr10:50323829-50323879	HCT-116	colon:	n/a
18	chr10:50323706-50323756	HEK293	kidney:	embryo
19	chr10:50323369-50323419	Jurkat	blood:	n/a
20	chr10:50323829-50323879	GM12892	blood:	n/a
21	chr10:50323832-50323882	HCM	heart:	n/a
22	chr10:50323832-50323882	PrEC	prostate:	n/a
23	chr10:50323825-50323875	NHDF-neo	bronchial:	n/a
24	chr10:50323708-50323758	CMK	blood:	n/a
25	chr10:50323825-50323875	NB4	blood:	n/a
26	chr10:50323706-50323756	AG09309	skin:	n/a
27	chr10:50323706-50323756	AoSMC	blood vessel:	n/a
28	chr10:50323708-50323758	ECC-1	luminal epithelium:	n/a
29	chr10:50323708-50323758	SKMC	muscle:	n/a
30	chr10:50323825-50323875	Caco-2	colon:	n/a
31	chr10:50323244-50323294	HUVEC	blood vessel:	n/a
32	chr10:50323825-50323875	GM12878	blood:	n/a
33	chr10:50323825-50323875	CMK	blood:	n/a
34	chr10:50323706-50323756	GM12878	blood:	n/a
35	chr10:50323832-50323882	NT2-D1	testis:	n/a
36	chr10:50323708-50323758	LNCaP	prostate:	n/a
37	chr10:50323706-50323756	SKMC	muscle:	n/a
38	chr10:50323708-50323758	HCPEpiC	choroid plexus:	n/a
39	chr10:50323244-50323294	U87	brain:	n/a
40	chr10:50323244-50323294	MCF10A-Er-Src	breast:	n/a
41	chr10:50323706-50323756	BJ	skin:	n/a
42	chr10:50323244-50323294	SK-N-SH_RA	brain:	n/a
43	chr10:50323829-50323879	SKMC	muscle:	n/a
44	chr10:50323825-50323875	PFSK-1	brain:	n/a
45	chr10:50323825-50323875	HCT-116	colon:	n/a
46	chr10:50323708-50323758	MCF10A-Er-Src	breast:	n/a
47	chr10:50323369-50323419	AG09309	skin:	n/a
48	chr10:50323825-50323875	HCF	heart:	n/a
49	chr10:50323832-50323882	PANC-1	pancreas:	n/a
50	chr10:50323832-50323882	GM12892	blood:	n/a

(count:6 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr10:50281055..50283973-chr10:50326395..50329291,2	K562	blood:
2	chr10:50321527..50324998-chr10:50325157..50328658,6	K562	blood:
3	chr10:50314500..50318570-chr10:50326499..50328270,3	K562	blood:
4	chr10:50322533..50324257-chr10:50507150..50509486,2	K562	blood:
5	chr10:50322283..50325786-chr10:50341748..50344745,3	K562	blood:
6	chr10:50322609..50324135-chr10:50326068..50328008,2	K562	blood:

No data

Variant related genes	Relation type
FAM170B-AS1	TF binding region
VSTM4	TF binding region
FAM170B-AS1	CpG island
VSTM4	CpG island
ENSG00000177354	chromatin interactions
ENSG00000165633	chromatin interactions
ENSG00000172538	chromatin interactions

Extended variants
information (count: 109 )
Associated
traits (count: 67 )

Variant overlapped rSNPs/rCNVs (count:109 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs567102368	chr10:50323295-50323296	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs141087200	chr10:50323348-50323349	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs546865154	chr10:50323374-50323375	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs568024249	chr10:50323402-50323403	Active TSS Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs571413350	chr10:50323438-50323439	Active TSS Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs538633530	chr10:50323704-50323705	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
7	rs143140276	chr10:50323709-50323710	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
8	rs368558610	chr10:50323752-50323753	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
9	rs114783688	chr10:50323799-50323800	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
10	rs142693718	chr10:50323832-50323833	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Active TSS Flanking Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
11	rs537264473	chr10:50323836-50323837	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Active TSS Flanking Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
12	rs115653734	chr10:50323857-50323858	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Active TSS Flanking Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
13	rs556022629	chr10:50323900-50323901	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
14	rs536964816	chr10:50323901-50323902	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
15	rs541399562	chr10:50323916-50323917	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
16	rs368697585	chr10:50323973-50323974	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
17	rs191782612	chr10:50324109-50324110	Weak transcription Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
18	rs181173019	chr10:50324135-50324136	Weak transcription Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
19	rs545016824	chr10:50324138-50324139	Weak transcription Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
20	rs563327754	chr10:50324169-50324170	Weak transcription Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
21	rs550722588	chr10:50324177-50324178	Weak transcription Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
22	rs185576168	chr10:50324179-50324180	Weak transcription Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
23	rs560791140	chr10:50324213-50324214	Weak transcription Bivalent Enhancer Enhancers Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
24	rs528300401	chr10:50324218-50324219	Weak transcription Bivalent Enhancer Enhancers Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
25	rs190181681	chr10:50324226-50324227	Weak transcription Bivalent Enhancer Enhancers Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
26	rs571543520	chr10:50324270-50324271	Weak transcription Bivalent Enhancer Enhancers Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs35007047	chr10:50324271-50324272	Weak transcription Bivalent Enhancer Enhancers Active TSS	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
28	rs12267388	chr10:50324331-50324332	Weak transcription Bivalent Enhancer Enhancers Active TSS	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
29	rs60458886	chr10:50324370-50324371	Weak transcription Bivalent Enhancer Enhancers Active TSS	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs536400329	chr10:50324376-50324377	Weak transcription Bivalent Enhancer Enhancers Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs12260698	chr10:50324389-50324390	Weak transcription Bivalent Enhancer Enhancers Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs566405275	chr10:50324467-50324468	Weak transcription Bivalent Enhancer Enhancers Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs535224877	chr10:50324623-50324624	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
34	rs553262884	chr10:50324630-50324631	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
35	rs578222621	chr10:50324640-50324641	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
36	rs35226374	chr10:50324652-50324653	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
37	rs78808677	chr10:50324674-50324675	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
38	rs11100988	chr10:50324685-50324686	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
39	rs540317025	chr10:50324818-50324819	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
40	rs575223051	chr10:50324871-50324872	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
41	rs555599037	chr10:50324904-50324905	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
42	rs11100989	chr10:50324915-50324916	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs369439612	chr10:50324994-50324995	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
44	rs114358695	chr10:50325034-50325035	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
45	rs11100990	chr10:50325055-50325056	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
46	rs540435870	chr10:50325078-50325079	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
47	rs577904707	chr10:50325079-50325080	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
48	rs148236020	chr10:50325089-50325090	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
49	rs532480100	chr10:50325108-50325109	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
50	rs550892758	chr10:50325109-50325110	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:67)

Disease	PMID	Source
Pancreatic endocrine tumor	17639061	CNVD
Gastric cancer	17908304	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Melanoma	18172304	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Ewing''s sarcoma	17952124	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	20724749	CNVD
Autism	22495311	CNVD
Esophageal cancer	21851588	CNVD
Prostate cancer	18632612	CNVD
Autism	18414403	CNVD
Cockayne syndrome	18421352	CNVD
Glioblastoma	16823260	CNVD
Medulloblastoma	16968546	CNVD
Neuroblastoma	17533364	CNVD
Cancer	21183584	CNVD
T-cell lymphomas	19863542	CNVD
Testicular germ cell tumor	18059402	CNVD
Squamous cell cancer	21044232	CNVD
Glioma	21971842	CNVD
Cancer	21637783	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Papillary thyroid carcinoma	21436994	CNVD
Hirschsprung''s Disease	21712996	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Obesity	21956041	CNVD
Renal cell carcinoma	18765545	CNVD
Developmental delay	21948486	CNVD
Dysmorphic features	21948486	CNVD
Epilepsy	21948486	CNVD
Breast cancer	21785460	CNVD
Intellectual disability	21948486	CNVD
Schizophrenia	23813976	CNVD
Intellectual disability	22045946	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Autism	21948486	CNVD
cleft palate	21948486	CNVD
Encephalopathy	21948486	CNVD
Lung cancer	18438408	CNVD
T-cell primary immunodeficiency	21948486	CNVD
Autism	22543975	CNVD
Breast cancer	21364760	CNVD
Developmental delay	21147756	CNVD
small cell lung cancer	20016488	CNVD
skeletal anomalies	21948486	CNVD
speech delay	21948486	CNVD
Colorectal cancer	16272173	CNVD
Breast cancer	21990379	CNVD
Myelofibrosis	22110671	CNVD
Metanephric adenoma	20802469	CNVD
Hypotonia	21948486	CNVD

Chromatin state (count:203 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr10:50321800-50324000	Bivalent/Poised TSS	Rectal Mucosa Donor 29	rectum
2	chr10:50322000-50324000	Active TSS	Duodenum Smooth Muscle	Duodenum
3	chr10:50322200-50323800	Active TSS	Right Ventricle	heart
4	chr10:50322200-50324000	Active TSS	Aorta	Aorta
5	chr10:50322200-50324600	Active TSS	Brain Cingulate Gyrus	brain
6	chr10:50322400-50323800	Active TSS	Left Ventricle	heart
7	chr10:50322400-50323800	Active TSS	Ovary	ovary
8	chr10:50322400-50323800	Active TSS	Skeletal Muscle Male	skeletal muscle
9	chr10:50322400-50324000	Bivalent/Poised TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
10	chr10:50322400-50324000	Active TSS	Right Atrium	heart
11	chr10:50322400-50324000	Active TSS	HSMMtube	muscle
12	chr10:50322600-50323400	Bivalent/Poised TSS	Primary T cells from cord blood	blood
13	chr10:50322600-50323400	Bivalent/Poised TSS	Rectal Mucosa Donor 31	rectum
14	chr10:50322600-50323800	Bivalent/Poised TSS	Fetal Intestine Large	intestine
15	chr10:50322600-50323800	Active TSS	Fetal Kidney	kidney
16	chr10:50322600-50323800	Active TSS	Psoas Muscle	Psoas
17	chr10:50322600-50323800	Active TSS	NH-A	brain
18	chr10:50322600-50324000	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
19	chr10:50322600-50324000	Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
20	chr10:50322600-50324000	Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
21	chr10:50322600-50324000	Active TSS	Fetal Lung	lung
22	chr10:50322600-50324000	Active TSS	Rectal Smooth Muscle	rectum
23	chr10:50322800-50323400	Bivalent/Poised TSS	ES-WA7 Cell Line	embryonic stem cell
24	chr10:50322800-50323400	Active TSS	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
25	chr10:50322800-50323400	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Female	--
26	chr10:50322800-50323400	Bivalent/Poised TSS	Muscle Satellite Cultured Cells	--
27	chr10:50322800-50323400	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin02	Skin
28	chr10:50322800-50323400	Flanking Active TSS	Liver	Liver
29	chr10:50322800-50323400	Bivalent/Poised TSS	HUVEC	blood vessel
30	chr10:50322800-50323600	Bivalent/Poised TSS	Pancreatic Islets	Pancreatic Islet
31	chr10:50322800-50323800	Active TSS	ES-I3 Cell Line	embryonic stem cell
32	chr10:50322800-50323800	Active TSS	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
33	chr10:50322800-50323800	Bivalent/Poised TSS	Colonic Mucosa	Colon
34	chr10:50322800-50323800	Active TSS	Fetal Stomach	stomach
35	chr10:50322800-50323800	Active TSS	HSMM	muscle
36	chr10:50322800-50324000	Active TSS	H9 Cell Line	embryonic stem cell
37	chr10:50322800-50324000	Bivalent/Poised TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
38	chr10:50322800-50324000	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
39	chr10:50322800-50324000	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
40	chr10:50322800-50324000	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
41	chr10:50322800-50324000	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
42	chr10:50322800-50324000	Active TSS	iPS DF 6.9 Cell Line	embryonic stem cell
43	chr10:50322800-50324000	Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
44	chr10:50322800-50324000	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin01	Skin
45	chr10:50322800-50324000	Bivalent/Poised TSS	Brain Germinal Matrix	brain
46	chr10:50322800-50324000	Active TSS	Brain Substantia Nigra	brain
47	chr10:50322800-50324000	Active TSS	Colon Smooth Muscle	Colon
48	chr10:50322800-50324000	Active TSS	Esophagus	oesophagus
49	chr10:50322800-50324000	Active TSS	NHDF-Ad	bronchial
50	chr10:50322800-50324400	Bivalent Enhancer	Primary T cells fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links